InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Hopper Jonathan Mark, Chief Medical Officer. Officer active across 1 company, notably Vericel Corp. In total, 28 filings have been logged. Split: 0 buy · 2 sells. History available since 30 June 2021. The latest transaction was filed on 2 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hopper Jonathan Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
5,000 sharesCommon StockSEC:0001140361-26-026930:0
5,000 sharesCommon StockSEC:0001140361-26-026930:1
5,000 sharesCommon StockSEC:0001140361-26-026930:2
5,000 sharesCommon StockSEC:0001140361-26-026930:3
3,472 shares@ US$10.950.0020% mcap16.8% of flowCommon StockSEC:0001140361-26-013334:0
350 sharesCommon StockSEC:0001140361-26-006973:0
3,000 sharesCommon StockSEC:0001140361-26-006312:0
1,652 shares@ US$18.002.4% of flowCommon StockSEC:0001140361-25-044348:0
10,000 shares@ US$18.0014.9% of flowCommon StockSEC:0001140361-25-033807:0
10,000 shares@ US$18.0017.8% of flowCommon StockSEC:0001140361-25-021415:0
10,000 shares@ US$18.0022.3% of flowCommon StockSEC:0001140361-25-007179:0
1,500 sharesCommon StockSEC:0001140361-25-006086:0
3,000 sharesCommon StockSEC:0001140361-25-005256:0
10,000 shares@ US$16.6620.3% of flowCommon StockSEC:0001140361-24-048294:0
10,000 shares@ US$10.9512.8% of flowCommon StockSEC:0001140361-24-040225:0
10,000 shares@ US$10.9513.0% of flowCommon StockSEC:0001140361-24-027027:0
3,000 shares0Common StockSEC:0001140361-24-009025:0
1,625 shares0Common StockSEC:0001140361-24-007424:0
5,000 shares@ US$10.956.5% of flowCommon StockSEC:0001140361-23-054439:0
2,325 shares0Common StockSEC:0001127602-23-006586:0
1,625 shares0Common StockSEC:0001127602-23-005118:0
650 shares0Common StockSEC:0001127602-23-003988:0
10,000 shares@ US$10.950.0058% mcap49.9% of flowCommon StockSEC:0001593968-22-000613:0
1,750 shares0Common StockSEC:0001593968-22-000517:0
1,625 shares0Common StockSEC:0001593968-22-000470:0
25 of 28 declarations
About Hopper Jonathan Mark
Hopper Jonathan Mark is Chief Medical Officer at Vericel Corp. The record shows 28 filings in total, and across the most recent filings held, covering the period from 2021-07-02 to 2026-06-30, the most frequent transaction type is option exercise. The buy and sell volumes shown for this recent sample are EUR 0 and EUR 0.
